HIV News and Research

RSS

Researchers investigate genetic mutations in sperm cells to help prevent birth defects

It's about preventing birth defects. Associate pharmaceutical sciences professor Wenfeng An and his team at South Dakota State University are investigating mobile DNA segments, known as L1s, in sperm cells with the goal to treat families at risk for genetic mutations before they conceive.

10 Aug 2017

Researchers find racial and gender disparities in survival of patients with anal cancer

Over the past 30 years, squamous cell carcinoma of the anus (SCCA) is one of the few cancers with steadily rising incidence in the United States, with the most rapid increase seen in black men.

9 Aug 2017

Postoperative patients use fewer opioid medications than prescribed after hernia surgery

A study by investigators from Massachusetts General Hospital and Newton-Wellesley Hospital found that patients prescribed opioid medications after inguinal (groin) hernia surgery used significantly fewer tablets than prescribed, even though they had received fewer than typically administered for such surgery.

9 Aug 2017

Researchers receive $3.8 million NIH grant to study medical marijuana's impact on opioid use for pain

The National Institutes of Health has awarded researchers at Albert Einstein College of Medicine and Montefiore Health System a five-year, $3.8 million grant for the first long-term study to test whether medical marijuana reduces opioid use among adults with chronic pain, including those with HIV.

8 Aug 2017

TMDU-led researchers identify protein critical to early stages of cellular HIV infection

When a virus enters a cell, one of the first steps in the process of infecting that cell is removal of the protein coat that surrounds the virus's genetic material.

8 Aug 2017

Congress revamps housing program to benefit areas where HIV is spreading

In a bipartisan push, Congress has restructured a federal program that provides housing assistance for people living with HIV to funnel more money into areas struggling to control the outbreak.

7 Aug 2017

HIV prevention and treatment being overlooked in older populations

When it comes to HIV prevention and treatment, there is a growing population that is being overlooked -- older adults -- and implicit ageism is partially responsible for this neglect, according to a presentation at the 125th Annual Convention of the American Psychological Association.

4 Aug 2017

HIV prevention drug to be trialed by Britain's NHS

After a High Court case, an HIV prevention drug is soon to be available on the NHS. NHS England has issued a statement saying that pre-exposure prophylaxis (PrEP) treatment for HIV shall be available to an initial 10,000 people for a trial period of three years.

3 Aug 2017

Injectable ART may have same effectiveness as standard oral treatments

Antiretroviral therapy (ART) intramuscularly administered may have the same effectiveness as current oral treatments.

3 Aug 2017

UM SOM researchers to study adaptive immune responses of infants with HIV exposure in utero

The University of Maryland School of Medicine's Institute for Global Health and the Institute of Human Virology have been awarded a $2 million five-year grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to study the impact exposure to HIV has on the immune systems of infants in utero and how those changes impact the ability of infants to fight off infections after birth.

2 Aug 2017

Woman's race, type of weight gain at midlife linked to risk of fatty heart

A woman's race and where on her body she packs on pounds at midlife could give her doctor valuable clues to her likelihood of having greater volumes of heart fat, a potential risk factor for heart disease, according to new research led by the University of Pittsburgh Graduate School of Public Health.

2 Aug 2017

Latency reversing agent makes dormant HIV-infected cells vulnerable to clearance

The ability for HIV to hide in the body in a dormant state makes curing the 40 million people living with the virus a challenge. Researchers at the University of North Carolina at Chapel Hill have shown the drug Vorinostat reverses this latency, causing resting CD4 T-cells to express HIV.

1 Aug 2017

Expert highlights CRISPR’s applications, limitations, and ethical concerns

"Good morning, doctor, I am here for my gene editing appointment." In the future, could this be a greeting heard in physician offices around the world? With the introduction of CRISPR technology, genetic material can now be more easily and precisely edited, even creating changes that can subsequently be inherited by offspring.

1 Aug 2017

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved updated labeling for Epclusa (sofosbuvir 400mg/velpatasvir 100mg), the first all-oral, pan-genotypic, once-daily single tablet regimen (STR) for the treatment of adults with chronic hepatitis C virus (HCV) infection, to include use in patients co-infected with HIV.

1 Aug 2017

HIV hides in more types of bone marrow cells than previously thought, research shows

Every day, 17 million HIV-infected people around the world swallow pills that keep the virus inside them at bay.

1 Aug 2017

Culture of silence around vaginal bleeding poses threat to women's health

The culture of silence around vaginal bleeding at all stages of life endangers women's health and is compounded by limited access to clean water, sanitation, and factual information in low and middle-income countries, according to a study conducted at Columbia University's Mailman School of Public Health. The findings are published in the online journal BMJ Global Health.

31 Jul 2017

Women diagnosed with HIV during pregnancy twice as likely to suffer more domestic violence

A diagnosis of HIV during pregnancy makes domestic violence twice as likely to start for some women after their baby has been born, according to new research led by a Drexel University researcher.

31 Jul 2017

Home-based kit could be effective means for HIV testing of heterosexuals

86% of heterosexuals who are at high risk for HIV would use a home-based test kit provided by mail and 99% would seek treatment based on a positive result.

31 Jul 2017

HIV testing at GP surgery is cost-effective and will save lives, study suggests

Offering HIV testing to people at health checks when they register at a new GP surgery in high-prevalence areas is cost-effective and will save lives, according to a study involving over 86,000 people from 40 GP surgeries, led by Queen Mary University of London and the London School of Hygiene & Tropical Medicine.

31 Jul 2017

Binding Site launches new antigens and antibodies for infectious/contagious diseases

The Immunologicals Group of The Binding Site is pleased to announce the launch of a number of new monoclonal antibodies and recombinant antigens focused on a variety of infectious/contagious disease states – including Cytomegalovirus (CMV), Hepatitis, HIV, Rubella, Syphilis, and Toxoplasmosis.

From Binding Site 29 Jul 2017

HIV News and Research

Researchers investigate genetic mutations in sperm cells to help prevent birth defects

Researchers find racial and gender disparities in survival of patients with anal cancer

Postoperative patients use fewer opioid medications than prescribed after hernia surgery

Researchers receive $3.8 million NIH grant to study medical marijuana's impact on opioid use for pain

TMDU-led researchers identify protein critical to early stages of cellular HIV infection

Congress revamps housing program to benefit areas where HIV is spreading

HIV prevention and treatment being overlooked in older populations

HIV prevention drug to be trialed by Britain's NHS

Injectable ART may have same effectiveness as standard oral treatments

UM SOM researchers to study adaptive immune responses of infants with HIV exposure in utero

Woman's race, type of weight gain at midlife linked to risk of fatty heart

Latency reversing agent makes dormant HIV-infected cells vulnerable to clearance

Expert highlights CRISPR’s applications, limitations, and ethical concerns

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

HIV hides in more types of bone marrow cells than previously thought, research shows

Culture of silence around vaginal bleeding poses threat to women's health

Women diagnosed with HIV during pregnancy twice as likely to suffer more domestic violence

Home-based kit could be effective means for HIV testing of heterosexuals

HIV testing at GP surgery is cost-effective and will save lives, study suggests

Binding Site launches new antigens and antibodies for infectious/contagious diseases

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News